Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2036

Annual patent cliff calendar for 2036 — US pharmaceutical patents by expiration date.

Patents
1,428

Quick answer

1,428 indexed pharmaceutical patents have expiration dates in 2036. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9375423

    Use of aminoindane compounds in treating overactive bladder and interstitial cystitis

    Asana BioSciences, LLC · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9375441

    Lactulose for bowel evacuation

    Cumberland Pharmaceuticals Inc. · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9375424

    Compounds that treat malaria and prevent malaria transmission

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9375474

    Compounds useful for inhibiting metastasis from cancer and methods using same

    Alliance Discovery, Inc. · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9375486

    Oligomer-containing benzamide-based compounds

    Nektar Therapeutics · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9376680

    Serpinc1 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9376480

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9376442

    Methylpyrrolopyrimidinecarboxamides

    TAKEDA GMBH · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9376681

    miR-29 mimics and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9376690

    Templated nanoconjugates

    Northwestern University · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9376448

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9376683

    Organic compositions to treat beta-ENaC-related diseases

    Arrowhead Pharmaceuticals, Inc. · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9376481

    Methods of promoting CNS neuronal repair by inhibiting LRP-1

    The Regents of the University of California · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 2016185873

    MONOCLONAL ANTIBODIES FOR TREATMENT OF CANCER

    GANYMED PHARMACEUTICALS AG [DE] · Granted Thu Jun 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9381236

    Interferon-β production modulating listeria strains and methods for using same

    The Regents of the University of California · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9381185

    Methods of inducing sedation

    The Regents of the University of California · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9381180

    Compositions and methods for treating chronic inflammation and inflammatory diseases

    Infirst Healthcare Limited · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9381202

    Salts of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9381228

    FKBP-L and uses thereof

    ALMAC DISCOVERY LIMITED · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9382200

    Process for the preparation of and crystalline forms of optical enantiomers of modafinil

    Teva Sante · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9381254

    Methods for preparing polymeric reagents

    Nektar Therapeutics · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9382188

    Aromatic ring compound

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9382214

    Processes for the preparation of uracil derivatives

    Neurocrine Biosciences, Inc. · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9382230

    Methods and compositions for modulating Ire1, SRC and ABL activity

    The Regents of the University of California · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9382277

    Pyrimido-pyridazinone compounds and methods of use thereof

    Asana BioSciences, LLC · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9382311

    HIV-1 broadly neutralizing antibodies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9382317

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9382302

    Lutzomyia longipalpis polypeptides and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9382327

    Anti-CD20 antibodies and methods of use

    VACCINEX, INC. · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9382547

    Human optimized Bacillus anthracis protective antigen

    United States of America as represented by the Secretary of the Air Force · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9382536

    Antisense antiviral compounds and methods for treating a filovirus infection

    Sarepta Therapeutics, Inc. · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9382256

    Formulation of Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9382213

    Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

    UNIVERSITY OF CONNECTICUT · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9388159

    Substituted diazaspiroalkanes as androgen receptor modulators

    The Regents of the University of California · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9387245

    Methods and compositions for the inhibition of fructokinase

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9387249

    Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9387205

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9387220

    Method for inducing hepatocyte proliferation and uses thereof

    CAN-FITE BIOPHARMA LTD. · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9387217

    Acyclic nucleoside phosphonate diesters

    The Regents of the University of California · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9387214

    Method of identifying therapies for pulmonary hypertension

    United Therapeutics Corporation · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9387224

    Treatment of specific cardiovascular conditions with nitrite

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9388195

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9388145

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9388163

    Multifunctional radical quenchers for the treatment of mitochondrial dysfunction

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9388222

    Modified Pseudomonas exotoxin A

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9388244

    Internalizing ErbB2 antibodies

    The Regents of the University of California · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9388408

    Oligonucleotide-based inhibitors comprising locked nucleic acid motif

    MIRAGEN THERAPEUTICS, INC. · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9388247

    Antibodies against cancer target block tumor growth, angiogenesis and metastatis

    The Regents of the University of California · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2036?

1,428 published patents in our USPTO index have expiration dates falling in calendar year 2036.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.